Get ROMVIMZA support

ROMVIMZA is here to help you move forward with tenosynovial giant cell tumor (TGCT)

Prescribed ROMVIMZA?

For those prescribed ROMVIMZA, MyROMVIMZA can help patients with medication trackers, appointment reminders and more.

You will find your access code to MyROMVIMZA in your ROMVIMZA welcome kit.

Download the app

Deciphera AccessPoint^™ here to help you start on ROMVIMZA

Insurance questions? Cost concerns? Let us point the way.

Financial help may be available no matter what insurance you have, or if you have no insurance at all:

If you have non-government insurance, such as through an employer, the Commercial Copay Program may cover ALL your out‑of‑pocket drug costs (as little as $0 copay)*
If you don’t have insurance, or if your health plan doesn’t cover ROMVIMZA, you may qualify for free medication*
Case Managers are available to help patients understand their benefits and other resources that may be available to them

Rapid Start Program: If eligible, you can start on ROMVIMZA if your insurance is delayed in making a coverage decision*
Bridge Program: Get help staying on ROMVIMZA if your insurance changes or there's a gap in your coverage*

Visit AccessPoint

*Terms and conditions apply. Not every patient is eligible. Copay program is subject to an annual benefit maximum.

Visit AccessPoint

Call us directly

1-833-4DACCES to speak to
a dedicated Case Manager

(1‑833‑432‑2237)Monday–Friday, 8AM–8PM ET

^†Deciphera is not associated with or connected to any of these organizations.

Stay connected with ROMVIMZA

Get important ROMVIMZA updates, keep in touch on Facebook, and get the help you need with the resources below.

We have resources, information, and tools to support you—plus, answers to questions on ROMVIMZA

ROMVIMZA™ (vimseltinib) patient brochure

ROMVIMZA Brochure

Everything you need to know about ROMVIMZA and how it can help your TGCT.

Download

What to Expect With ROMVIMZA

A guide on what to expect when taking ROMVIMZA.

Download

Doctor Discussion Guide

A tool to help you talk to your doctor about ROMVIMZA, no matter where you are in your journey.

Download

Enroll in AccessPoint

Get insurance help, financial guidance, and more by enrolling.

Get Started

Get more information today

Deciphera AccessPoint enrollment is fast and easy. Just complete our Patient Enrollment Form to begin your journey.

Get started

Important Safety Information

What is the most important information I should know about ROMVIMZA?

ROMVIMZA can cause serious side effects, including liver problems. Increased liver enzymes in your blood are common with ROMVIMZA.

Your healthcare provider will do blood tests to check for liver problems:

before starting treatment with ROMVIMZA,
2 times each month for the first 2 months of treatment,
then 1 time every 3 months for the first year of treatment and as clinically indicated thereafter.

If you develop liver problems during treatment with ROMVIMZA, your healthcare provider may temporarily stop treatment, decrease your dose, or permanently stop treatment depending on how severe your liver problems are.

Tell your healthcare provider right away if you develop any signs or symptoms of liver problems during treatment with ROMVIMZA including yellowing of your skin or the white part of your eyes, dark urine, lack or loss of appetite, right upper stomach‑area (abdomen) pain or tenderness, feeling overly tired, nausea, vomiting, fever, rash, and itching.

Before taking ROMVIMZA, tell your healthcare provider about all of your medical conditions, including if you:

have or had liver problems.
are pregnant or plan to become pregnant. ROMVIMZA can harm your unborn baby.

Females who are able to become pregnant:

Your healthcare provider will do a pregnancy test before you start treatment with ROMVIMZA.
Use effective birth control (contraception) during treatment with ROMVIMZA and for 1 month after the last dose. Talk to your healthcare provider about birth control methods that may be right for you.
Tell your healthcare provider right away if you become pregnant or you think you may be pregnant during treatment with ROMVIMZA.

Males with female partners who are able to become pregnant:

Use effective birth control (contraception) during treatment with ROMVIMZA and for 1 month after the last dose.
Tell your healthcare provider right away if your female partner becomes pregnant or thinks she may be pregnant during treatment with ROMVIMZA.

are breastfeeding or plan to breastfeed. It is not known if ROMVIMZA passes into your breast milk. Do not breastfeed during treatment with ROMVIMZA and for 1 month after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Taking ROMVIMZA with certain other medicines may affect the way that ROMVIMZA or the other medicine works and may increase your risk of side effects.

What are the possible side effects of ROMVIMZA?

ROMVIMZA can cause serious side effects.

Allergic reactions to FD&C Yellow No. 5 and FD&C Yellow No. 6. ROMVIMZA 20 mg capsules contain the inactive ingredients FD&C Yellow No. 5 (tartrazine) and FD&C Yellow No. 6 (Sunset Yellow FCF). ROMVIMZA 14 mg capsules contain the inactive ingredient FD&C Yellow No. 6 (Sunset Yellow FCF). FD&C Yellow No. 5 (tartrazine) can cause allergic-type reactions (including bronchial asthma) in certain people, especially people who also have an allergy to aspirin. FD&C Yellow No. 6 (Sunset Yellow FCF) can also cause allergic reactions. Tell your healthcare provider if you get hives, rash, or trouble breathing during treatment with ROMVIMZA.

The most common side effects of ROMVIMZA include:

swelling around your eyes
tiredness
rash
increased cholesterol levels in your blood

swelling of your hands or feet
swelling of your face
decreased white blood cells
itchy skin

ROMVIMZA may cause fertility problems, which may affect your ability to have children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of ROMVIMZA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is ROMVIMZA?

ROMVIMZA is a prescription medicine used to treat adults with symptomatic tenosynovial giant cell tumor (TGCT) when surgery may make the symptoms worse or cause severe problems.

It is not known if ROMVIMZA is safe and effective in children.

Please click for the full Prescribing Information, including Medication Guide.

What is ROMVIMZA?

ROMVIMZA is a prescription medicine used to treat adults with symptomatic tenosynovial giant cell tumor (TGCT) when surgery may make the symptoms worse or cause severe problems.

It is not known if ROMVIMZA is safe and effective in children.

Get ROMVIMZA support

ROMVIMZA is here to help you move forward with tenosynovial giant cell tumor (TGCT)

Prescribed ROMVIMZA?

Deciphera AccessPoint.css-y612ns{top:-0.3em;}™ here to help you start on ROMVIMZA

Call us directly

Visit us online

Send an email

Advocacy groups, for you†

Stay connected with ROMVIMZA

We have resources, information, and tools to support you—plus, answers to questions on ROMVIMZA

ROMVIMZA Brochure

What to Expect With ROMVIMZA

Doctor Discussion Guide

Enroll in AccessPoint

Get more information today

Deciphera AccessPoint^™ here to help you start on ROMVIMZA

Advocacy groups, for you^†